Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.00 (0.00%)
Bid:
1.80
Ask:
1.90
Spread: 0.10 (5.556%)
Market Cap: £2.18m
RDT Live PriceLast checked at - London Stock Exchange

Intraday Rosslyn Data Share Chart

Trading Statement

13 Jan 2022 07:00

RNS Number : 2786Y
Rosslyn Data Technologies PLC
13 January 2022
 

Rosslyn Data Technologies plc

("RDT", the "Group" or the "Company")

Trading update

RDT provides the following trading update.

2021 marked the start of a transformational period for Rosslyn. Following the appointment of Paul Watts as CEO in April 2021, a new leadership team has been put in place and a full operational review has been conducted in order to ensure that the business is able to provide solutions to the continually evolving needs of its customer base.

With an increased corporate focus on supply chain resilience, risk and sustainability, RDT's clients are placing more focus on procurement savings and efficiencies and the Board believes that the Group's core RAPiD product is becoming ever more relevant.

Accordingly, the Board has focused its efforts and invested heavily on developing the next generation of the Group's core RAPiD product, which it will launch before the end of March 2022. The product is currently in beta testing and the Board is extremely pleased that feedback, so far, has been overwhelmingly positive. The next generation of the RAPiD product includes, amongst other things:

· a transformation of the UI/UX interface to expand user adoption across a much broader range of procurement professionals;

· a move towards a pure best of breed cloud delivery;

· a foundation architecture built to deliver advanced intelligent automation and machine learning into the category management functions; and

· an enhancement to the product's data mining capability into a specific product called Data Factory.

Delivering growth and profitability in RDT's core market is the Board's key priority, and the operational review focused on how best to achieve this. The review identified that the Integritie and Langdon Systems acquisitions, whilst performing well since they became part of the Group, have limited crossover in terms of customer base or strategic rationale. As a result, the Board will continue to consider how to best capitalize on the Group's core business, which may include the divestment of these non-core elements of the Group, in order to deliver the best value to shareholders as a whole. The Board believes that following a strategy to enable RDT to operate as a single market data company, focused on procurement with a dynamic in-house operating model and culture will best position the Group to drive growth and deliver shareholder value in the medium to long term.

During the year, the Group has invested in its growth, with a number of key hires being made, whilst also remaining disciplined on costs and the Board will continue to explore ways to minimise costs.

The Group has made good progress so far this financial year, including winning deals for a top 10 global pharmaceutical business, a top 3 global beverage company, and a top 5 UK Law firm. At the same time, there has been a focus on exiting non-profitable business lines, to enable the Company to focus on larger, more profitable contracts. However, and as has been reported previously, larger contracts have lengthy lead times and Covid restrictions that have been experienced across the economy have lengthened these further. Whilst the Company will continue to work hard to secure further contracts before the end of the financial year, the challenges being faced, mean that the Board is taking a more conservative view on the outcome for the year ending 30 April 2022 and now expects revenue to be no less than £6.0m, with ARR to be at least £5.1m and a corresponding impact on EBITDA.

Paul Watt, CEO, commenting, "Like many businesses we have not been immune to the effects of the pandemic and this is reflected in our anticipated financial performance for the current calendar year. However, with a refreshed leadership team, a great core product and a clear strategy now in place I believe that there are significant opportunities available to the Group to drive growth and deliver shareholder value and am excited to look to the future."

 

This announcement contains inside information.

 

 

 

 

Rosslyn Data Technologies plc

Paul Watts, Chief Executive Officer

+44(0) 7555 144983+44(0)20 3285 8008

James Appleby, Chairman

+44 (0) 7940 560624

Cenkos Securities,Nominated Adviser, Broker

Stephen Keys/Camilla Hume/Giles Balleny

 

+44(0)20 7397 8900

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKLLFFLFLBBBK
Date   Source Headline
8th May 20262:35 pmRNSHolding(s) in Company
7th May 20264:42 pmRNSHolding(s) in Company
30th Apr 20264:30 pmRNSTotal Voting Rights
23rd Apr 20267:00 amRNSContract renewals worth $1.5m
15th Apr 20263:36 pmRNSHolding(s) in Company
15th Apr 20263:29 pmRNSHolding(s) in Company
15th Apr 20263:21 pmRNSHolding(s) in Company
14th Apr 20265:26 pmRNSHolding(s) in Company
14th Apr 20264:07 pmRNSDirector/PDMR Dealings
13th Apr 20263:35 pmRNSResult of General Meeting and TVR
1st Apr 20263:01 pmRNSHolding(s) in Company
1st Apr 202612:15 pmRNSDirector Dealings
31st Mar 20264:30 pmRNSTotal Voting Rights
31st Mar 202612:53 pmRNSResult of Retail Offer
26th Mar 20267:00 amRNSResult of Placing and Posting of Circular
25th Mar 20265:20 pmRNSRetail Offer
25th Mar 20265:15 pmRNSProposed Fundraising
28th Jan 20267:00 amRNSInterim Results
19th Jan 20264:29 pmRNSHolding(s) in Company
27th Nov 202511:28 amRNSResult of AGM
31st Oct 20257:00 amRNSNotice of AGM
27th Oct 20252:07 pmRNSChange of Registered Address
27th Oct 20257:00 amRNSFinal Results and Publication of Annual Report
23rd Oct 20259:41 amRNSHolding(s) in Company
21st Oct 20257:00 amRNSNotice of Results and Trading Update
27th Aug 20252:51 pmRNSHolding(s) in Company
8th Aug 202512:16 pmRNSHolding(s) in Company
18th Jul 202510:59 amRNSHolding(s) in Company
19th Jun 20257:00 amRNSTrading Update
28th May 202511:14 amRNSHolding(s) in Company
12th May 202512:19 pmRNSHolding(s) in Company
4th Apr 20259:59 amRNSHolding(s) in Company
17th Mar 20251:42 pmRNSHolding(s) in Company
14th Mar 20257:00 amRNSBoard Changes
12th Mar 20252:38 pmRNSHolding(s) in Company
12th Mar 20252:33 pmRNSHolding(s) in Company
6th Mar 20254:43 pmRNSHolding(s) in Company
6th Mar 202512:58 pmRNSHolding(s) in Company
6th Mar 202512:54 pmRNSHolding(s) in Company
5th Mar 20257:00 amRNSTrading Update
27th Feb 20255:14 pmRNSHolding(s) in Company
4th Feb 20255:22 pmRNSHolding(s) in Company
30th Jan 20257:00 amRNSInterim Results
10th Dec 20247:00 amRNSGrant and Cancellation of Options
3rd Dec 202410:44 amRNSResult of AGM
27th Nov 20245:47 pmRNSHolding(s) in Company
8th Nov 20247:00 amRNSNotice of AGM
5th Nov 20244:48 pmRNSHolding(s) in Company
31st Oct 20242:47 pmRNSTotal Voting Rights
31st Oct 20241:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.